Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Conditions: Cirrhosis; Cirrhosis, Liver; Cirrhosis Early; Cirrhosis Due to Hepatitis B; Cirrhosis Advanced; Cirrhosis Infectious; Cirrhosis Alcoholic; Cirrhosis, Biliary; Cirrhosis Cryptogenic; Cirrhosis Due to Hepatitis C; Cirrhosis Due to Primary Sclerosing Cholangitis Intervention: Drug: Rosuvastatin Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The Cleveland Clinic; Columbia University; Weill Medical College of Cornell University; Duke University; Mayo Clinic; University of Miami; Universi...
Source: ClinicalTrials.gov - April 27, 2023 Category: Research Source Type: clinical trials
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Metastatic Solid Tumor Interventions: Drug: TPX-0005; Drug: Metformin Hydrochloride; Drug: Digoxin; Drug: Rosuvastatin Calcium Sponsor: Turning Point Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials
